top of page

Methods found suitable within the European Union for demonstrating freedom from extraneous agents of

According to Directive 2001/82/EC and relevant European Pharmacopoeia (Ph. Eur.) monographs (i.e. 0062, 0030, 5.2.4., 5.2.5.), immunological veterinary medicinal products and materials of biological origin used in their production should be demonstrated to be free from contamination with extraneous agents.


READ MORE


#LegislationRegulatoryAffairs #RegulatoryAffairsVeterinary #GoodManufacturingPractices #LegislationQualityManagement

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page